|
NSUN7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.701700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.416460E-03 |
| Normal-vs-Stage2 |
5.555700E-02 |
| Normal-vs-Stage3 |
4.563400E-04 |
| Normal-vs-Stage4 |
1.190440E-01 |
| Stage1-vs-Stage2 |
8.204600E-01 |
| Stage1-vs-Stage3 |
4.006100E-02 |
| Stage1-vs-Stage4 |
4.249000E-01 |
| Stage2-vs-Stage3 |
2.188200E-01 |
| Stage2-vs-Stage4 |
6.267600E-01 |
| Stage3-vs-Stage4 |
6.735200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.483860E-02 |
| Normal-vs-AfricanAmerican |
2.195000E-03 |
| Normal-vs-Asian |
2.064100E-03 |
| Caucasian-vs-AfricanAmerican |
4.519800E-01 |
| Caucasian-vs-Asian |
1.286550E-01 |
| AfricanAmerican-vs-Asian |
4.034200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.074400E-02 |
| Normal-vs-Female |
1.52029999999082E-05 |
| Male-vs-Female |
1.374360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.203000E-03 |
| Normal-vs-Extreme_Weight |
2.135800E-01 |
| Normal-vs-Obese |
1.444470E-02 |
| Normal-vs-Extreme_Obese |
3.030200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.474800E-01 |
| Normal_Weight-vs-Obese |
6.026200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.458200E-01 |
| Extreme_Weight-vs-Obese |
6.985200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.391200E-01 |
| Obese-vs-Extreme_Obese |
9.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.020800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.142300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.324300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.373730E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.948200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.908000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.606200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.495800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.609700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.806990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.795400E-01 |
| Normal-VS-Type2 PRCC |
6.85239998077236E-09 |
| Normal-VS-KIRP CIMP |
2.24020801908864E-12 |
| Normal-VS-Unclassified PRCC |
2.756100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.45479999555687E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.49309999919467E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
8.978300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.635000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.524500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.8460000052516E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01730000000322E-05 |
| Normal-vs-N1 |
1.596600E-03 |
| Normal-vs-N2 |
2.0174000000539E-06 |
| N0-vs-N1 |
3.812200E-01 |
| N0-vs-N2 |
2.549700E-02 |
| N1-vs-N2 |
2.406400E-01 |
|
|
